Lercanidipine Hydrochloride Generics [uk] (Lercanidipine Hydrochloride)

Lercanidipine Hydrochloride is used to manage conditions within the hypertension disease family, providing blood pressure control through vascular smooth‑muscle relaxation.

• Essential hypertension: reduces systolic and diastolic pressure to target levels.
• Isolated systolic hypertension: lowers elevated systolic pressure, especially in older patients.
• Hypertension in elderly patients: offers once‑daily dosing with a favorable tolerability profile.

• Lercanidipine Hydrochloride selectively inhibits L‑type calcium channels in vascular smooth muscle, preventing calcium influx that triggers contraction. This inhibition leads to vasodilation of peripheral arteries, decreasing systemic vascular resistance and consequently lowering arterial blood pressure without significant effect on cardiac contractility.

Lercanidipine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Headache: mild to moderate intensity.
• Flushing: sensation of warmth, especially on the face.
• Peripheral edema: swelling of ankles or feet.
• Dizziness or light‑headedness.
• Tachycardia: increased heart rate.
• Palpitations: awareness of heartbeat.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure leading to fainting.
• Myocardial infarction: rare occurrence of heart attack.
• Hepatic dysfunction: abnormal liver enzymes.
• Allergic reactions: rash, itching, or urticaria.
• Angioedema: swelling of lips, tongue, or throat.
• Life‑threatening arrhythmias: irregular heart rhythms.

When prescribing or dispensing Lercanidipine Hydrochloride, consider the following safety measures.

• Blood pressure monitoring: check regularly to avoid excessive lowering.
• Discontinuation: do not stop abruptly without medical advice.
• Hepatic impairment: use with caution; dose adjustment may be required.
• Severe aortic stenosis: avoid or use only under specialist supervision.
• Elderly patients: start at the lowest effective dose.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lercanidipine Hydrochloride can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma levels.
• Concomitant antihypertensives (e.g., ACE inhibitors, ARBs): risk of additive hypotension.
• Grapefruit juice: can elevate drug concentration.

Moderate Interactions (Monitor Closely):\n- CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce effectiveness.

• Diuretics: may enhance blood‑pressure‑lowering effect.
• Beta‑blockers: monitor for excessive heart‑rate reduction.
• NSAIDs: may blunt antihypertensive response.
• Lithium: monitor lithium levels for potential increase.